Alpha Genesis Inc.
Yemassee, SC
- UEI
- H7E8FHEF7ND5
- CAGE
- 3CUA8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Primary
- 112990 All Other Animal Production
- 115210 Support Activities for Animal Production
- 541380 Testing Laboratories and Services
- 541690 Other Scientific and Technical Consulting Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541940 Veterinary Services
- 561210 Facilities Support Services
- SAM.gov registration date
- Physical address
- 95 Castle Hall Rd, Yemassee, SC 29945, USA
- Website
- alphagenesisinc.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Consumer Staples
- Food, Beverage & Tobacco
- Food Products
- Packaged Foods & Meats
- SIC code
- 20 Food & Kindred Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Research and development | Veterans Integrated Service Network 5 | $46,900 | |
| AGI-alpha genesis INC; 75N98021D00017; per diem, testing and shipping cost for VRC | Office of Logisitics and Acquisition Operations | $300,000 | |
| Niaid SPF macaque breeding colonies | National Institute of Allergy and Infectious Diseases | $8,408,640 | |
| Per diem. Non-human primate acquisition, testing, transportation and housing | Office of Logisitics and Acquisition Operations | $110,000 | |
| Per diem, testing and shipping cost associated with the IRF | Office of Logisitics and Acquisition Operations | $45,000 |
About Alpha Genesis Inc.
Alpha Genesis Inc. is a for-profit Subchapter S corporation headquartered in Yemassee, South Carolina, specializing in providing nonhuman primates and related biomedical research services to federal government agencies. The company is a key provider of nonhuman primates (NHPs) for critical research areas including infectious diseases, COVID-19 vaccine development, medical research, immunology, and mental health studies. Alpha Genesis maintains extensive breeding colonies and offers comprehensive services such as NHP acquisition, testing, transportation, housing, and colony maintenance for various federal research institutions.
Through its federal contract awards, Alpha Genesis has consistently provided per diem, testing, shipping, and maintenance services for nonhuman primate colonies across multiple National Institutes of Health (NIH) institutes, including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute of Mental Health (NIMH), National Heart, Lung, and Blood Institute (NHLBI), and the Vaccine Research Center (VRC). The company has been awarded numerous delivery order contracts ranging from $18,000 to $1.3 million, focusing on maintaining specific pathogen-free (SPF) macaque, cynomolgus, and rhesus monkey colonies. These contracts consistently do not utilize set-aside designations, indicating Alpha Genesis competes broadly in the federal contracting landscape. The company has also performed sub-contract work, such as a contract with Takeda Vaccines Inc. for evaluating immunogenicity and protection of a Zika vaccine.
Alpha Genesis holds two significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles. The first, awarded by NIAID, is a $48 million contract for specific pathogen-free macaque breeding colonies, with an ultimate completion date of September 29, 2031. The second, awarded by the NIH Office of Logistics and Acquisition Operations, is a $33.4 million contract for non-human primate acquisition, testing, transportation, and housing, running through July 31, 2026. These IDIQ contracts enable Alpha Genesis to support a wide range of biomedical research programs, including infectious diseases, immunology, organ transplantation, cancer research, and mental health studies. Task orders under these contracts have funded comprehensive services such as colony maintenance, per diem care, testing, and transportation of specific pathogen-free primates across multiple research institutes, demonstrating the company's critical role in supporting federal biomedical research infrastructure.
Contract vehicles
Quick answers
What is Alpha Genesis Inc.'s UEI?
Alpha Genesis Inc.'s Unique Entity ID (UEI) in SAM.gov is H7E8FHEF7ND5.
What is Alpha Genesis Inc.'s CAGE code?
Alpha Genesis Inc.'s CAGE code is 3CUA8.
What is Alpha Genesis Inc.'s primary NAICS code?
Alpha Genesis Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Alpha Genesis Inc. located?
Alpha Genesis Inc.'s physical address in SAM.gov is 95 Castle Hall Rd, Yemassee, SC 29945, USA.
Is Alpha Genesis Inc. registered in SAM.gov?
Yes. Alpha Genesis Inc.'s SAM.gov registration is active through August 28, 2027.
Which contract vehicles does Alpha Genesis Inc. hold?
Alpha Genesis Inc. holds a place on 5 federal contract vehicles, including Non-Human Primates 2010-2016, Non-Human Primates 2016-2021 and Rhesus Macaque Breeding Program 2014.
What is Alpha Genesis Inc.'s most recent federal award?
Alpha Genesis Inc.'s most recent federal contract award is Research and development (36C24526P0658), from Veterans Integrated Service Network 5, on September 25, 2026.
On GovTribe
See Alpha Genesis Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors